Oculus Innovative Sciences Announces Completion of Two Randomized Controlled Clinical Trials of Microcyn(R) Technology in China Dec 18, 2007
Oculus Innovative Sciences Completes Enrollment of Phase II Trial of Microcyn(R) Technology in Treatment of Mildly Infected Diabetic Foot Ulcers Dec 5, 2007
Oculus Innovative Sciences Wins Federal Court Ruling in Intellectual Property Rights Litigation Nov 19, 2007
Oculus Innovative Sciences Announces Fiscal Second Quarter 2008 Quarterly Results and Clinical Update Nov 12, 2007
Oculus Innovative Sciences Schedules Fiscal Second Quarter 2008 Financial Results Release and Conference Call Nov 8, 2007
Oculus Innovative Sciences Microcyn Technology Data to be Presented by Researchers at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy Sep 17, 2007
